Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

(2014) Lisa Pleyer et al.   LEUKEMIA RESEARCH

Azacitidine in untreated acute myeloid leukemia: A report on 149 patients

(2013) Sylvain Thépot et al.   AMERICAN JOURNAL OF HEMATOLOGY

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

(2013) Lisa Pleyer et al.   Journal of Hematology & Oncology

Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts

(2013) L.H. van der Helm et al.   LEUKEMIA RESEARCH

Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine

(2012) M. Gavillet et al.   HAEMATOLOGICA

Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies

(2011) S. Kayser et al.   BLOOD

Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named p

(2011) Lieke H. van der Helm et al.   BRITISH JOURNAL OF HAEMATOLOGY

Azacitidine for the treatment of patients with acute myeloid leukemia

(2011) Luca Maurillo et al.   CANCER

Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum

(2011) D. A. Breems et al.   HAEMATOLOGICA

Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study

(2011) Haifa K. Al-Ali et al.   LEUKEMIA & LYMPHOMA

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

(2010) S. Thepot et al.   BLOOD

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

(2009) Pierre Fenaux et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

(2009) Pierre Fenaux et al.   LANCET ONCOLOGY

Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

(2008) Dimitri A. Breems et al.   JOURNAL OF CLINICAL ONCOLOGY

Acute Myeloid Leukemia in the Elderly

(2008) Hervé Dombret et al.   SEMINARS IN ONCOLOGY